Structure-function relationship of estrogen receptors in cardiovascular pathophysiological models

Thrombosis Research

Volumn 130, Issue SUPPL.1, 2012, Pages S7-

  Arnal, Jean François ^a   Valéra, Marie Cécile ^a   Payrastre, Bernard ^a   Lenfant, Francoise ^a   Gourdy, Pierre ^a  

^a Université de Toulouse   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ORAL CONTRACEPTIVE AGENT; RALOXIFENE; STEROID RECEPTOR; TAMOXIFEN;

ARTICLE; ATHEROMA; BREAST CANCER; CEREBROVASCULAR ACCIDENT; DRUG RECEPTOR BINDING; ESTROGEN ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; REPRODUCTION; SEXUAL DEVELOPMENT; STRUCTURE ACTIVITY RELATION; THROMBOSIS;

EID: 84867003386     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.08.261     Document Type: Article

References (63)

1. Table 27. Life expectancy at birth ayoa, and at 75 years, of age brasUS, selected years 1900-2004, pg 192. In: National Center for Health Statistics Health U, States WCoTitHoA, Hyattsville MAahwcgnd, hus07.pdf#027. Accessed: April 17. life expectancy.
2. V.C. Jordan The past, present, and future of selective estrogen receptor modulation Ann N Y Acad Sci 949 2001 72 79
3. V.C. Jordan Tamoxifen: a most unlikely pioneering medicine Nat Rev Drug Discov 2 2003 205 213
4. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 2005 1687 1717
5. J.E. Rossouw, R.L. Prentice, J.E. Manson, L. Wu, D. Barad, V.M. Barnabei, M. Ko, A.Z. LaCroix, K.L. Margolis, and M.L. Stefanick Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause JAMA 297 2007 1465 1477
6. J.C. Stevenson, H.N. Hodis, J.H. Pickar, and R.A. Lobo Coronary heart disease and menopause management: the swinging pendulum of HRT Atherosclerosis 207 2009 336 340
7. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, M.L. Stefanick, R.D. Jackson, S.A. Beresford, B.V. Howard, K.C. Johnson, J.M. Kotchen, and J. Ockene Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
8. G.L. Anderson, M. Limacher, A.R. Assaf, T. Bassford, S.A. Beresford, H. Black, D. Bonds, R. Brunner, R. Brzyski, B. Caan, R. Chlebowski, D. Curb, M. Gass, J. Hays, G. Heiss, S. Hendrix, B.V. Howard, J. Hsia, A. Hubbell, R. Jackson, K.C. Johnson, H. Judd, J.M. Kotchen, L. Kuller, A.Z. LaCroix, D. Lane, R.D. Langer, N. Lasser, C.E. Lewis, J. Manson, K. Margolis, J. Ockene, M.J. O'Sullivan, L. Phillips, R.L. Prentice, C. Ritenbaugh, J. Robbins, J.E. Rossouw, G. Sarto, M.L. Stefanick, L. Van Horn, J. Wactawski-Wende, R. Wallace, and S. Wassertheil-Smoller Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial JAMA 291 2004 1701 1712
9. G.L. Anderson, R.T. Chlebowski, J.E. Rossouw, R.J. Rodabough, A. McTiernan, K.L. Margolis, A. Aggerwal, J. David Curb, S.L. Hendrix, F. Allan Hubbell, J. Khandekar, D.S. Lane, N. Lasser, A.M. Lopez, J. Potter, and C. Ritenbaugh Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin Maturitas 55 2006 103 115
10. F. Grodstein, M.J. Stampfer, J.E. Manson, G.A. Colditz, W.C. Willett, B. Rosner, F.E. Speizer, and C.H. Hennekens Postmenopausal estrogen and progestin use and the risk of cardiovascular disease N Engl J Med 335 1996 453 461
11. T.B. Clarkson, and S.E. Appt Controversies about HRT-lessons from monkey models Maturitas 51 2005 64 74
12. P. Holm, H.L. Andersen, M.R. Andersen, E. Erhardtsen, and S. Stender The direct antiatherogenic effect of estrogen is present, absent, or reversed, depending on the state of the arterial endothelium. A time course study in cholesterol-clamped rabbits Circulation 100 1999 1727 1733
13. J.F. Arnal, P.Y. Scarabin, F. Tremollieres, H. Laurell, and P. Gourdy Estrogens in vascular biology and disease: where do we stand today? Curr Opin Lipidol 18 2007 554 560
14. K. Miyagawa, J. Rosch, F. Stanczyk, and K. Hermsmeyer Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm Nat Med 3 1997 324 327
15. E. Barrett-Connor Hormones and heart disease in women: the timing hypothesis Am J Epidemiol 166 2007 506 510
16. F. Lenfant, F. Tremollieres, P. Gourdy, and J.F. Arnal Timing of the vascular actions of estrogens in experimental and human studies: Why protective early, and not when delayed? Maturitas 68 2011 165 173
17. D.M. Herrington, and K.P. Klein Invited review: Pharmacogenetics of estrogen replacement therapy J Appl Physiol 91 2001 2776 2784
18. K.K. Koh, and B.K. Yoon Controversies regarding hormone therapy: Insights from inflammation and hemostasis Cardiovasc Res 70 2006 22 30
19. M. Canonico, E. Oger, G. Plu-Bureau, J. Conard, G. Meyer, H. Levesque, N. Trillot, M.T. Barrellier, D. Wahl, J. Emmerich, and P.Y. Scarabin Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study Circulation 115 2007 840 845
20. C. Renoux, S. Dell'aniello, E. Garbe, and S. Suissa Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study BMJ 340 2010 c2519
21. Valera MC, Gratacap MP, Gourdy P, Lenfant F, Cabou C, Toutain CE, Marcellin M, Saint Laurent N, Sie P, Sixou M, Arnal JF, Payrastre B. Chronic estradiol treatment reduces platelet responses and protects mice from thromboembolism through the haematopoietic estrogen receptor alpha. Blood. in press.
22. P. Ascenzi, A. Bocedi, and M. Marino Structure-function relationship of estrogen receptor alpha and beta: impact on human health Mol Aspects Med 27 2006 299 402
23. A. Krust, S. Green, P. Argos, V. Kumar, P. Walter, J.M. Bornert, and P. Chambon The chicken oestrogen receptor sequence: homology with v-erbA and the human oestrogen and glucocorticoid receptors EMBO J 5 1986 891 897
24. L. Tora, J. White, C. Brou, D. Tasset, N. Webster, E. Scheer, and P. Chambon The human estrogen receptor has two independent nonacidic transcriptional activation functions Cell 59 1989 477 487
25. N.J. McKenna, and B.W. O'Malley Combinatorial control of gene expression by nuclear receptors and coregulators Cell 108 2002 465 474
26. D.P. Edwards Regulation of signal transduction pathways by estrogen and progesterone Annu Rev Physiol 67 2005 335 376
27. R. Metivier, G. Penot, M.R. Hubner, G. Reid, H. Brand, M. Kos, and F. Gannon Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter Cell 115 2003 751 763
28. M.T. Tzukerman, A. Esty, D. Santiso-Mere, P. Danielian, M.G. Parker, R.B. Stein, J.W. Pike, and D.P. McDonnell Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions Mol Endocrinol 8 1994 21 30
29. M. Berry, D. Metzger, and P. Chambon Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen EMBO J 9 1990 2811 2818
30. C.L. Smith, and B.W. O'Malley Coregulator function: a key to understanding tissue specificity of selective receptor modulators Endocr Rev 25 2004 45 71
31. K.H. Kim, and J.R. Bender Membrane-initiated actions of estrogen on the endothelium Mol Cell Endocrinol 308 2009 3 8
32. E.R. Levin Integration of the extranuclear and nuclear actions of estrogen Mol Endocrinol 19 2005 1951 1959
33. S. Kousteni, T. Bellido, L.I. Plotkin, C.A. O'Brien, D.L. Bodenner, L. Han, K. Han, G.B. DiGregorio, J.A. Katzenellenbogen, B.S. Katzenellenbogen, P.K. Roberson, R.S. Weinstein, R.L. Jilka, and S.C. Manolagas Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity Cell 104 2001 719 730
34. M. Razandi, A. Pedram, S.T. Park, and E.R. Levin Proximal events in signaling by plasma membrane estrogen receptors J Biol Chem 278 2003 2701 2712
35. F. Acconcia, P. Ascenzi, A. Bocedi, E. Spisni, V. Tomasi, A. Trentalance, P. Visca, and M. Marino Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol Mol Biol Cell 16 2005 231 237
36. C.W. Wong, C. McNally, E. Nickbarg, B.S. Komm, and B.J. Cheskis Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade Proc Natl Acad Sci U S A 99 2002 14783 14788
37. Q. Lu, D.C. Pallas, H.K. Surks, W.E. Baur, M.E. Mendelsohn, and R.H. Karas Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha Proc Natl Acad Sci U S A 101 2004 17126 17131
38. M.E. Mendelsohn, and R.H. Karas Molecular and cellular basis of cardiovascular gender differences Science 308 2005 1583 1587
39. T. Simoncini Mechanisms of action of estrogen receptors in vascular cells: relevance for menopause and aging Climacteric 12 Suppl. 1 2009 6 11
40. C. Bolego, A. Cignarella, P. Sanvito, V. Pelosi, F. Pellegatta, L. Puglisi, and C. Pinna The acute estrogenic dilation of rat aorta is mediated solely by selective estrogen receptor-alpha agonists and is abolished by estrogen deprivation J Pharmacol Exp Ther 313 2005 1203 1208
41. J. Hartman, K. Lindberg, A. Morani, J. Inzunza, A. Strom, and J.A. Gustafsson Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts Cancer Res 66 2006 11207 11213
42. T.H. Charn, E.T. Liu, E.C. Chang, Y.K. Lee, J.A. Katzenellenbogen, and B.S. Katzenellenbogen Genome-wide dynamics of chromatin binding of estrogen receptors alpha and beta: mutual restriction and competitive site selection Mol Endocrinol 24 2010 47 59
43. R.J. Handa, S. Ogawa, J.M. Wang, and A.E. Herbison Roles for oestrogen receptor beta in adult brain function J Neuroendocrinol 24 2012 160 173
44. S.R. Hammes, and E.R. Levin Minireview: Recent advances in extranuclear steroid receptor actions Endocrinology 152 2011 4489 4495
45. D.B. Lubahn, J.S. Moyer, T.S. Golding, J.F. Couse, K.S. Korach, and O. Smithies Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene Proc Natl Acad Sci U S A 90 1993 11162 11166
46. R.H. Karas, H. Schulten, G. Pare, M.J. Aronovitz, C. Ohlsson, J.A. Gustafsson, and M.E. Mendelsohn Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice Circ Res 89 2001 534 539
47. S. Dupont, A. Krust, A. Gansmuller, A. Dierich, P. Chambon, and M. Mark Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes Development 127 2000 4277 4291
48. L. Brouchet, A. Krust, S. Dupont, P. Chambon, F. Bayard, and J.F. Arnal Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta Circulation 103 2001 423 428
49. B. Darblade, C. Pendaries, A. Krust, S. Dupont, M.J. Fouque, J. Rami, P. Chambon, F. Bayard, and J.F. Arnal Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor Circ Res 90 2002 413 419
50. G. Pare, A. Krust, R.H. Karas, S. Dupont, M. Aronovitz, P. Chambon, and M.E. Mendelsohn Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury Circ Res 90 2002 1087 1092
51. C. Pendaries, B. Darblade, P. Rochaix, A. Krust, P. Chambon, K.S. Korach, F. Bayard, and J.F. Arnal The AF-1 activation-function of ERalpha may be dispensable to mediate the effect of estradiol on endothelial NO production in mice Proc Natl Acad Sci U S A 99 2002 2205 2210
52. M.D. Iafrati, R.H. Karas, M. Aronovitz, S. Kim, T.R. Sullivan Jr., D.B. Lubahn, T.F. O'Donnell Jr., K.S. Korach, and M.E. Mendelsohn Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice Nat Med 3 1997 545 548
53. J.F. Arnal, C. Fontaine, A. Billon-Gales, J. Favre, H. Laurell, F. Lenfant, and P. Gourdy Estrogen receptors and endothelium Arterioscler Thromb Vasc Biol 30 2010 1506 1512
54. A. Billon-Gales, C. Fontaine, C. Filipe, V. Douin-Echinard, M.J. Fouque, G. Flouriot, P. Gourdy, F. Lenfant, H. Laurell, A. Krust, P. Chambon, and J.F. Arnal The transactivating function 1 of estrogen receptor alpha is dispensable for the vasculoprotective actions of 17{beta}-estradiol Proc Natl Acad Sci U S A 106 2009 2053 2058
55. M. Kos, S. Denger, G. Reid, K.S. Korach, and F. Gannon Down but not out? A novel protein isoform of the estrogen receptor alpha is expressed in the estrogen receptor alpha knockout mouse J Mol Endocrinol 29 2002 281 286
56. A. Billon-Gales, A. Krust, C. Fontaine, A. Abot, G. Flouriot, C. Toutain, H. Berges, A.P. Gadeau, F. Lenfant, P. Gourdy, P. Chambon, and J.F. Arnal Activation function 2 (AF2) of estrogen receptor-{alpha} is required for the atheroprotective action of estradiol but not to accelerate endothelial healing Proc Natl Acad Sci U S A 108 2011 13311 13316
57. J.F. Couse, and K.S. Korach Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20 1999 358 417
58. P.A. Arias-Loza, V. Jazbutyte, and T. Pelzer Genetic and pharmacologic strategies to determine the function of estrogen receptor alpha and estrogen receptor beta in cardiovascular system Gend Med 5 Suppl. A 2008 S34 S45
59. C. Zhao, K. Dahlman-Wright, and J.A. Gustafsson Estrogen receptor beta: an overview and update Nucl Recept Signal 6 2008 e003
60. M.C. Antal, A. Krust, P. Chambon, and M. Mark Sterility and absence of histopathological defects in nonreproductive organs of a mouse ERbeta-null mutant Proc Natl Acad Sci U S A 105 2008 2433 2438
61. A. Pedram, M. Razandi, F. O'Mahony, D. Lubahn, and E.R. Levin Estrogen receptor-beta prevents cardiac fibrosis Mol Endocrinol 24 2010 2152 2165
62. K.L. Chambliss, Q. Wu, S. Oltmann, E.S. Konaniah, M. Umetani, K.S. Korach, G.D. Thomas, C. Mineo, I.S. Yuhanna, S.H. Kim, Z. Madak-Erdogan, A. Maggi, S.P. Dineen, C.L. Roland, D.Y. Hui, R.A. Brekken, J.A. Katzenellenbogen, B.S. Katzenellenbogen, and P.W. Shaul Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice J Clin Invest 120 2010 2319 2330
63. B.S. Katzenellenbogen, and J.A. Katzenellenbogen Biomedicine. Defining the "S" in SERMs Science 295 2002 2380 2381